Press Release

<< Back
April 30, 2015 at 7:00 AM EDT

Verastem to Present at Upcoming Investor Conferences

BOSTON--(BUSINESS WIRE)--Apr. 30, 2015-- Verastem, Inc. (NASDAQ:VSTM), focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, today announced that the company will participate at the following upcoming investor conferences:

  • Deutsche Bank 40th Annual Healthcare Conference on Wednesday, May 6, 2015 at 3:30 p.m. ET at the InterContinental Hotel in Boston
  • Mizuho Securities USA Third Annual Healthcare Corporate Access Day on Tuesday, May 5, 2015, the Omni Berkshire Hotel in New York City

A live audio webcast of the Deutsche Bank presentation will be available on the company's website at www.verastem.com. An archived presentation will be available for 90 days.

About Verastem, Inc.

Verastem, Inc. (NASDAQ:VSTM) is discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells. Cancer stem cells are an underlying cause of tumor recurrence and metastasis. Verastem is developing small molecule inhibitors of signaling pathways that are critical to cancer stem cell survival and proliferation: FAK and PI3K/mTOR. For more information, please visit www.verastem.com.

Source: Verastem, Inc.

Verastem, Inc.
Brian Sullivan, 781-292-4214
bsullivan@verastem.com

Investor Contact

getty
John Doyle

VP Investor Relations & Finance
781.292.4279
jdoyle@verastem.com

Joe Rayne

Argot Partners
617.340.6075
joseph@argotpartners.com